Unexpectedly, MLL inhibition in PI3K-activated cancer cell line models increased PI3K effector signaling as indicated by increased AKT phosphorylation, which was abrogated with combined PI3K and MLL inhibition (Fig. 2A; Supplementary Fig. S2A–S2C). This evidence concerns the gene KMT2A and cancer.